Congratulations to UMC Utrecht’s Daniëlle Krijgsman, András Spaan and Nienke Vrisekoop, shortlisted for the GSLS PhD Supervisor of the Year Awards 2026! 🎉 Celebrating the people who help PhD candidates thrive. Winners will be announced October 29.
#UMCUtrecht#GSLS#PhD
The research group of Nienke @vrisekoop has a #PhD position to develop flow-cytometry approaches, using blood cells, and translating these to characterization of inhaled particles such as #microplastics and pollen and their immune effects.
More info here: edu.nl/hbtbt
Routine health data could help GPs identify higher-risk patients with respiratory infections, concluded Merijn Rijk MD in his PhD thesis that he defended yesterday at @UMCUtrecht.
Read the full article here: edu.nl/78xq9
🇳🇱→🇿🇦
Dutch HIV innovation now routine in SAF: measure dolutegravir with viral load. No drug? Resistance unlikely (NPV≈98%). Saves ~23% costs, targets testing, improves adherence talks. Adopted by SAF Health.
More here: edu.nl/e7ybj#HIV#GlobalHealth#Innovation
Unexpected findings in a new preprint on oseltamivir for influenza: In the REMAP-CAP study, critically ill adults on the ICU receiving 5 or 10 days of oseltamivir had higher 90-day mortality than those who received no antiviral treatment.
More info here: edu.nl/8fa9f
🔬 Ready to explore new therapeutic targets for autoimmune diseases?
@UMCUtrecht is looking for a Postdoctoral Researcher to discover and characterize new inhibitory receptors in autoimmunity.
📅 Apply by 25 August 2026
👉edu.nl/b4aea#Postdoc#Immunology#receptor
🔬 Interested in immunology and translational research? @UMCUtrecht is looking for a #PhD candidate to investigate tertiary lymphoid structures across different diseases and explore their potential as therapeutic targets.
🗓️ Apply before 31 August 2026
👉 edu.nl/9nv3w
New research led by @UMCUtrecht shows that targeted school closures can improve pandemic response. The most effective strategy depends on which age groups are driving transmission at different stages of an outbreak. #Pandemic#PublicHealth
More here: edu.nl/cmryf
Research by @UMCUtrecht PhD candidate Anniek Stuut shows that engineering of donor stem cell grafts can reduce the risk of graft-versus host disease while preserving the ability of hematopoietic stem cell transplantation to fight cancer
Full article here: edu.nl/tnrw9
ALT Left: Anniek Stuut defending her PhD thesis (July 10, 2026)
Right: the cover of Anniek Stuut's PhD thesis
At @UMCUtrecht, we have a position for a postdoc in the research group of Prof. Karijn Suijkerbuijk at the Department of Medical Oncology. The project will focus on immune checkpoint inhibitor toxicity and efficacy.
For more info, click here: edu.nl/ecx7v
S. aureus causes life-threatening infections in some people, wereas others remain unaffected. PhD research by Tristan van der Linden at @UMCUtrecht provides new insights into why people respond differently to this common skin bacterium.
More here: edu.nl/9j4t6
At @CTI_UMCUtrecht we have a position for a Postdoc Molecular and Translational Immunology. The project aims to test if targeting ERAP2 can selectively remove pathogenic EBV-infected B cells in multiple sclerosis.
More info here: edu.nl/6h9qq
Research by @UMCUtrecht PhD candidate Emily Kallen MD shows that diagnosis and treatment of food #allergy can become more accurate, more personalized and, for some patients, even partly carried out at home.
Read the full article at our research website: edu.nl/erbxm
PhD candidate Zijian Ye at @UMCUtrecht proposes that treatment of implant infections will likely require more than antibiotics alone. Instead, combining different targeted therapies that attack #biofilm may offer a more effective approach.
More info here edu.nl/my9pg
PhD research by Reineke Soegiharto MD at @UMCUtrecht aimed at improving urticaria care in daily clinical practice, showed that some patients develop long-term disease that can be predicted early based on the clinical picture.
Read the full article here: edu.nl/46pex
A new study shows that a combination of two cheap and widely available anti-rheumatic drugs (#leflunomide and #hydroxychloroquine) offers the first effective treatment for patients with #Sjögren’s disease with systemic disease activity.
Read more here: edu.nl/nqrhv
ALT ESSDAI scores over 24 weeks of treatment with leflunomide–hydroxychloroquine or placebo: (A) Mean ESSDAI corrected for baseline, indicating the treatment effect of leflunomide–hydroxychloroquine versus placebo after 8 weeks, 16 weeks, and 24 weeks. Error bars indicate SEM. (B) Within-treatment paired ESSDAI differences between baseline and 24 weeks, with each line representing one patient. p values indicate the difference compared with baseline
Researchers at @UMCUtrecht have discovered an underappreciated way in which immune cells quickly respond to infections. With longread RNA sequencing, they show that ‘alternative RNA splicing’ plays an important role in shaping #immune responses
read more: edu.nl/bvmtc
ALT From left to right: PI Jorg van Loosdregt, first author Alejandra Bodelón and co-PI Bas Vastert
Het @UMCUtrecht heeft een promotieplek voor een arts-onderzoeker binnen Reumatologie & Klinische Immunologie voor klinisch onderzoek naar moeilijk behandelbare reumatoïde artritis en vroege detectie van antistofdeficiëntie.
Sluit op 31/7.
Meer info hier: edu.nl/4ymeh
At @UMCUtrecht we have a position for a postdoc in IgA-like antibody development. You wil be involved in development, optimization and scale-up of IgA antibody production platforms, and next-generation antibodies (deadline 4/6).
Read more at edu.nl/r6dba
Interplay between gut bacteria and a deficiency of the virus-neutralizing #antibody IgA may play a role in children that have recurrent tespiratory tract infections, research from @radboudumc and @UMCUtrecht shows.
Read more: edu.nl/yg9ax